Regeneron Pharma revenue rises 37 pct
February 09, 2016 at 06:39 AM EST
Feb 9 (Reuters) - Regeneron Pharmaceuticals Inc reported a 37 percent rise in quarterly revenue as sales of its blockbuster eye drug Eylea increased 44 percent in the United States.
